Pulmonary Hypertension Clinical Trials in Providence, Rhode Island

5 studies are recruiting for pulmonary hypertension in Providence, Rhode Island right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

   This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD) on a background inhaled treprostinil.

   Stage

   Phase 2

   Ages

   18 to 85

   Site

   Clinical Research Site, Providence, Rhode Island

   Locations

   13 in total

   Run by

   Pulmovant, Inc.

   See if you can join NCT07333183 on ClinicalTrials.gov

2. Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

   Patients with pulmonary arterial hypertension (PAH) are at increased risk of muscle loss and decreased physical activity. This study will aim to (1) understand the way in which muscle loss occurs in PAH, particularly the role of fat surrounding the heart, and (2) look at the impact muscle loss has …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Rhode Island Hospital, Providence, Rhode Island

   Locations

   2 in total

   Run by

   University of Pennsylvania

   See if you can join NCT07132788 on ClinicalTrials.gov

3. Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

   The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Providence VA Medical Center, Providence, Rhode Island

   Locations

   3 in total

   Run by

   Eko Devices, Inc.

   See if you can join NCT05873387 on ClinicalTrials.gov

4. Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

   The investigators will study whether the drug tadalafil improves shortness of breath in 126 Veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs. The investigators will also assess whether tadalafil improves quality of life, home daily physical activity, e…

   Stage

   Phase 2

   Ages

   35 to 89

   Site

   Providence VA Medical Center, Providence, RI, Providence, Rhode Island

   Locations

   5 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT05937854 on ClinicalTrials.gov

5. Pulmonary Hypertension Association Registry

   The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

   Stage

   Not phased

   Ages

   0 and older

   Site

   Rhode Island Hospital, Providence, Rhode Island

   Locations

   52 in total

   Run by

   Pulmonary Hypertension Association, Inc.

   See if you can join NCT04071327 on ClinicalTrials.gov